Top Markets
Coin of the day
Pure Biologics Spólka Akcyjna Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjna

PUR
주식 순위 #33926
Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise,... Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise, concentrating its efforts on the discovery and development of novel biological pharmaceuticals and targeted, non-systemic treatments. The company's key therapeutic interests span immuno-oncology, various autoimmune conditions, and rare diseases. Its capabilities encompass the entire process for antibodies and aptamers, from their initial creation and purification to detailed analysis and characterization. Additionally, Pure Biologics is skilled in the design, development, and rigorous validation of diagnostic and research assays, while also advancing technology platforms for the precise selection of active therapeutic molecules. A significant offering is PureApta, a adaptable platform engineered for the in vitro selection of modified aptamers, suitable for both medical treatment and diagnostic applications. The firm is also actively pursuing the development of localized therapies aimed at assisting individuals afflicted by neurological autoimmune disorders, including conditions like neuromyelitis optica and myasthenia gravis. Founded in 2010, Pure Biologics Spólka Akcyjna is headquartered in Wroclaw, Poland.
주가
$0.8248572
마지막 동기화: 2026-08-07
시가총액
$6.60M
변동 (1일)
35.02%
변동 (1년)
-54.35%
국가
PL
거래 Pure Biologics Spólka Akcyjna (PUR)

카테고리

Pure Biologics Spólka Akcyjna (PUR)의 배당 수익률 기록
Pure Biologics Spólka Akcyjna (주식 심볼: PUR)의 배당 수익률 (TTM)은 2026 기준으로 0입니다.
지난 5년 평균 배당 수익률: 0.00%
Pure Biologics Spólka Akcyjna (PUR)의 배당 수익률 기록: 2026 ~ 2026
연도별 말 기준 배당 수익률 (TTM)
연도 배당 수익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 배당 수익률 (TTM)